Neuro 2 Flashcards

1
Q

describe patho of Alzheimer’s

A
  • plaques and tangles (increase in beta amyloid proteins)
  • disrupts neuron to neuron signaling and causes inflammation
  • accelerates degeneration of brain
  • chronic, progressive, degenerative disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

who is it more common in and how is it prevented

A

women

balanced diet, exercise, avoid brain trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe the mini mental exam

A

orientation, repetition, naming objects, reading and comprehension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the MME used for in Alzheimer’s

A

does NOT diagnose, determines severity of impairment

lower score=greater impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

when is Alzheimer’s diagnosed

A

when ALL other possibilities are ruled out

only definitive confirmation is autopsy at death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe the early stages of Alzheimer’s

A

(1-4 yrs)
forget names, misplace things, change in personality and behavior, decrease in performance, loss of judgement, wandering, decreased sense of smell, sundowning, confusion at night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe middle/late stages of Alzheimer’s

A

(2-3 yrs)
intellectual and cog impairment, disorientated to person place and time, agitated, loss of ability to care for self, speech and language deficit, incontinent, totally dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is drug therapy focused on with Alzheimer’s

A

s/s of disease not deterioration
cholinesterase inhibitor-slows onset of cog decline
*may need SSRIs for depression and anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the only FDA approved drug to slow pace of deterioration in Alzheimer’s

A

Namenda

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

nursing care with Alzheimer’s

A
  • manage confusion/ limit environmental distractors
  • prevent injury (ID badge d/t wandering)
  • quiet room and implement daily ROUTINE
  • clock, calendar helpful in EARLY stages only
  • uses all other resources BEFORE restraints
  • walking helps redirect pt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

communication with Alzheimer’s

A
  • avoid raising voice
  • therapeutic communication
  • reality orientation
  • avoid why questions
  • address role strain with care taker
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe patho of Huntington’s

A

rare, hereditary

  • autosomal dominant (kids have 50% chance of getting it if one parent has it)
  • defect in DNA “CAG” strand-too many (>36)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what do the too many CAG strands in Huntington’s lead to

A

decrease in GABA and increase in glutamate

these normally helps control movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe signs of Huntington’s

A
  • rapid, jerky choreiform movement
  • CANNOT stop movements
  • snake like movement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

overview of Huntington’s (onset)

A
  • begins 30-50 yrs, progresses 5-15 yrs
  • no cure, genetic counseling early age to determine if have disease
  • death occurs within 10-20 yrs
  • dementia and depression may occur
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what determines the onset of Huntington’s

A

number of CAG repeats

ie/ if 50 CAG, onset will be earlier than if 36 CAG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

patho of multiple sclerosis

A
  • autoimmune
  • chronic, progressive, degenerative disease
  • demyelination of neurons in CNS (brain and spinal)
  • BBB is breached and WBC break through, deposit antibodies on myelin sheath and attack it (causes delay in neuron signal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

broadly describe MS

A
  • sensory, motor, and cognitive problems
  • regeneration of myelin sheath causes periods of exacerbation and remission
  • onset between 15-50, more common in women
  • progressive but NOT fatal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

diagnostic of MS

A

plaques and lesions on MRI- scar tissue of breakdown of myelin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

s/s of MS

A

EYE (ocular are first symptoms)

blurred vision, diplopia, scotomas, nystagmus, intention tremor, dysmetria

21
Q

what are the upper motor neurons responsible for

A

brain and spinal cord

starting and stopping contractions/movement

22
Q

motor and sensory signs of MS

A

spasticity of muscles, dysmetria, poor coordination. loss of balance, scanning speech, eye problems
numbness/tingling, bowel and bladder dysfunction, sexual dysfunction, mental status changes

23
Q

what do lower motor neurons do

A

start contractions

24
Q

MS therapy

A
chemotherapy-cannot use for more than 2-3 yrs d/t toxicity
immunomodulators
glatiramer actae
natalizumab
corticosteroids-reduce inflammation
25
Q

what is the primary therapy for MS

A

immunosuppressive therapy (IM or SQ)

26
Q

amyotrophic lateral sclerosis is also known as

A

Lou Gehrig’s

or ALS

27
Q

patho of ALS

A

rapidly progressive, degenerative, FATAL disease
no muscle nourishment
destruction of motor cells (upper and lower)- degeneration of entire neuron

28
Q

broadly describe ALS

A

FATAL
does not affect cognition (pt is fully aware)
muscles that control breathing eventually freeze up resulting in death (about 2-5 yrs after death)
age of onset is 40-70

29
Q

s/s of ALS

A

weakness, atrophy, fasciculation of muscles of hands and arms, fatigue, muscle atrophy, tongue atrophy, dysarthria

30
Q

what is twitching also called

A

fasciculation

31
Q

diagnosis of ALS

A

EMG, neuro exam
CPK is elevated (d/t muscle cell death)
myelogram to rule out other conditions

32
Q

drug therapy for ALS

A

Rilutek- helps with symptoms

no treatment or cure

33
Q

what eventually occurs with ALS

A

spastic paralysis of limbs

die from resp complications

34
Q

what motor neurons are associated with ALS

A

lower and upper(degeneration of whole neuron, cannot start or stop contraction of muscle)

35
Q

what is Gullian Barre syndrome characterized by

A

muscle weakness and areflexia

36
Q

describe patho of Gullian Barre

A
  • immunologic reaction
  • similar to MS, BUT BBB not breached, cells attack myelin sheath in peripheral nerves
  • progressive, peripheral nervous system (not CNS)
37
Q

3 stages of Gullian Barre syndrome

A

initial: onset until further deterioration (1-3 wks)
plateau: little change (several days to 2 wks)
recovery: coincides with myelination and axonal regeneration (4-6 mos) may take yrs and it may reoccur

38
Q

what are the symptoms based on and what is the disease thought to be the result of

A

nerves affected

resembles a virus? cells attack what they think is the virus

39
Q

describe the most common type of Gullian Barre syndrome

A
  • Ascending (bottom of body (feet) to lungs/head)
  • weakness/numbness in leg
  • paresthesia, hypotonia, areflexia
  • eventual resp function decrease may cause hospitalization
40
Q

what is paresthesia

A

numbness or tingling caused by nerves

41
Q

what is hyptonia

A

abnormally low muscle tone

42
Q

what is areflexia

A

absence of neurologic reflexes

43
Q

diagnosis of Gullian Barre

A

clinical picture, EMG determines muscle weakness

44
Q

treatment of Gullian barre

A

immunotherapy
plasmapheresis
resp support-intbation
supportive (symptoms)

45
Q

broadly describe myastheria gravis

A

grave muscle weakness
defect of myoneural junction
possibly autoimmune

46
Q

patho of myastheria gravis

A
  • antibodies attack Ach which causes a decrease in Ach and subsequent decrease in muscle contraction
  • possible thymus gland hyperplasia
47
Q

hallmarks of MG

A
  • weakness of certain voluntary muscles
  • improvement of muscle strength at rest
  • dramatic improvement of muscle strength with anticholinesteratse drugs
48
Q

s/s of myastheria gravis

A

ptosis, diplopia, unable to smile, dysphagia, loss of bowel/bladder control, resp weakness, Myastheria crisis